South Australian Health and Medical Research Institute
16
4
6
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
6.3%
1 terminated/withdrawn out of 16 trials
80.0%
-6.5% vs industry average
19%
3 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
The Bloom Infant Probiotic (BIP) Study
Role: lead
Pasteurised Donor Human Milk Supplementation for Term Babies
Role: collaborator
Antibiotics and Vaccine Immune Responses Study
Role: lead
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Role: collaborator
Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation
Role: collaborator
Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study
Role: collaborator
Prenatal Iodine Supplementation and Early Childhood Neurodevelopment
Role: lead
Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia
Role: collaborator
Do Iron Supplements Impact the Gut Microbiome of Women of Reproductive Age?
Role: lead
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.
Role: collaborator
Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII)
Role: collaborator
Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination
Role: collaborator
Trial of Thiamine Supplementation in Cambodia
Role: collaborator
In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems
Role: collaborator
CER-001 Atherosclerosis Regression ACS Trial
Role: collaborator
Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
Role: collaborator
All 16 trials loaded